“Flow Cytometry based ’Acute Myeloid Leukemia Maturity Score’ is a Novel Marker for Predicting Relapse in Acute Myeloid Leukemia: A Prospective Observational Study: AML Maturity Score Predicts Relapse in AML” (2022) International Journal of Medical Science And Diagnosis Research, 6(2). doi:10.32553/ijmsdr.v6i2.910.